Search

You searched for "paralysis"

346 results found

An update on BIA-ALCL

1 June 2019 | | PMFA - Breast Surgery, PMFA - General Plastic Surgery
The author discusses the concerns and new restrictions on breast implants due to cases of breast implant associated-anaplastic large cell lymphoma – should we be worried? Breast implants, first introduced in the 1960s, have continued to evolve, having survived a...

Acid attacks: part 2

1 October 2019 | | PMFA - Breast Surgery, PMFA - Facial Plastic Surgery, PMFA - General Plastic Surgery
The PMFA Journal Editor Andrew Burd continues with his exploration of the optimum treatment protocol for managing the devastating injuries wrought by acid attacks (see Part 1 here). In part one of this series I outlined the evolution of my...

Cellulite therapy in 2022 – new treatment options making grades for the new year

30 March 2022 | | PMFA - Aesthetic Medicine, PMFA - Dermatology
World-renowned dermatologist Michael H Gold introduces two of the newest FDA-approved modalities for the treatment of the common skin condition cellulite. Cellulite is one of the most common skin concerns for women. It is estimated that between 80-98% of women...

Old dogs can learn new tricks: the use of an often overlooked treatment modality for pathologically fractured mandibles

1 December 2021 | | PMFA - Maxillofacial Surgery
Figure 1: Timeline detailing key events in the patient’s treatment. Whilst commonly affecting the feet, spine and hips in adults, osteomyelitis (OM) can also present to the oral and maxillofacial surgery (OMFS) clinic as pathology of the jaws. Case reports...

Recurrent corneal erosions secondary to isotretinoin use

4 March 2021 | | PMFA - Dermatology
This article originally appeared in Eye News Dec/Jan 2021 Isotretinoin (13–cis-retinoic acid) is the first line treatment for moderate to severe nodulocystic or papulopustular acne [1,2]. Although it is a safe medication, it has several adverse side-effects, including ophthalmic manifestations,...

Impact of medical NGOs and a new collaborative approach: the case of Guinea with Mercy Ships

26 October 2021 | | PMFA - General Plastic Surgery
Mercy Ships (MS) is a global Christian charity that follows the 2000-year-old model of Jesus to bring hope and healing to those suffering from disability, disfigurement, and disease. This article by Professor Diallo and Drs Ugai and Conde, details a...

How I Do It - Contouring the lower jaw (non-surgical)

1 October 2014 | | PMFA - Aesthetic Medicine
It is important to invest time in analysing the lower aspect of the face whilst in discussion with the patient to establish a mutual agreement as to the level of desired correction along with the choice of product. I find...

Xanthelasma

1 April 2014 | | PMFA - Aesthetic Medicine, PMFA - Dermatology
Although the lesion known as Xanthelasma was first described by Addison and Gall in 1851 [1] it was recorded some 300 years previously in the famous painting of the Mona Lisa by Leonardo da Vinci. In this painting, Leonardo da...

Hand rejuvenation with injectable fillers

1 June 2019 | | PMFA - CPD, PMFA - Aesthetic Medicine, PMFA - Hand & Wrist Surgery
The author, an internationally recognised aesthetic dermatologist and Faculty Member for this year’s 5CC meeting in Barcelona, provides an expert guide to the use of injectable fillers in hand rejuvenation. Ageing of the hands can result in discrepancy between a...

Hormones, ageing and skinspan

6 August 2024 | | PMFA - Dermatology
Skinspan refers to the years of life during which skin remains healthy, youthful and attractive and is influenced by genetic, metabolic and lifestyle factors. While ultraviolet (UV) exposure is a potent environmental driver of skin ageing, our hormones play a...

Stratifying preoperative risk in revision augmentation: the six Cs

1 February 2016 | | PMFA - Breast Surgery
Breast augmentation is the most frequently performed cosmetic surgical procedure in the UK [1], and with an increasing number of providers, plastic surgeons are managing revisions without information pertaining to the original procedure. Anticipating the features of successive generations of...

Melasma treatment – what have we achieved in 42 years?

1 April 2019 | | PMFA - Aesthetic Medicine, PMFA - Dermatology
Melasma is a hyperpigmentation disorder which has been the subject of intense research over the last 40 years. As yet no definitive therapeutic strategy has been demonstrated to eradicate it or to avoid relapse. The author provides an up to...